MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-DL-08-0035438
Medicamen Life Sciences Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.09 Cr
▲ 60% YoY
Net loss · FY 2025
₹2.9 Cr
Net margin -26.1%
EBITDA · FY 2025
-₹2.68 Cr
EBITDA margin -24.2%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹10 Cr
Issued & subscribed
Open charges
₹9.42 Cr
Satisfied ₹1 Cr
Company age
4 yrs
Est. 2022
Employees · EPFO
114
Provident fund records
About Medicamen Life Sciences Private Limited
Data last updated:
Medicamen Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Medicamen Biotech Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 August 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2022PTC403121. Its GSTIN is 07AAQCM0862K1Z1 (Delhi).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹10 Cr. It is led by directors including Kamal Kishore Pahwa (Managing Director) and Shaival Saurabh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1009 & 1010 10th Floor Chiranjiv Tower, Nehru Place New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.09 Cr, a growth of 60% compared to the previous year. For the same year it recorded a net loss of ₹2.9 Cr (net margin -26.1%) and EBITDA of -₹2.68 Cr (EBITDA margin -24.2%).
The company has about 114 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹9.42 Cr and satisfied charges of ₹1 Cr on record.
Medicamen Life Sciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-DL-08-0035438). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medicamen.com.
Company details
CIN U24290DL2022PTC403121
Registration Number 403121
Incorporation Date 12 August 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Parent Company Medicamen Biotech Limited
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-DL-08-0035438
Recognitions & Rankings of Medicamen Life Sciences
Contact details
Medicamen Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its website is medicamen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1009 & 1010 10th Floor Chiranjiv Tower, Nehru Place New Delhi, Delhi, India – 110019
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medicamen Life Sciences Private Limited, buy the company report.
Comprehensive company report
Medicamen Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medicamen Life Sciences is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Medicamen Life Sciences Private Limited, buy the company report.
Financials of Medicamen Life Sciences Private Limited
FY 2025 filings availableMedicamen Life Sciences Private Limited reported revenue of ₹11.09 Cr (up 60% YoY) for FY 2025.
Revenue · FY 2025
₹11.09 Cr ▲ 60%
Net loss · FY 2025
₹2.9 Cr margin -26.1%
EBITDA · FY 2025
-₹2.68 Cr margin -24.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 60%
EBITDA CAGR growth
1 year
▲ 28%
Revenue rose 60% in the latest year. EBITDA rose 28% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹2.68 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹2.9 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -24.2% | ||
| Net Profit Margin | -26.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Medicamen Life Sciences Private Limited, buy the company report.
Board of directors of Medicamen Life Sciences Private Limited
Medicamen Life Sciences has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shaival Saurabh | Director | 12 Aug 2025 | 1 Years 3 Months | Current |
| Rahul Bishnoi | Director | 12 Aug 2022 | 4 Years 3 Months | Current |
| Sham Goel Also directs: Shivalik Rasayan Limited, Medicamen Biotech Limited, Garne Threads Private Limited and 1 more | Director | 12 Aug 2025 | 1 Years 3 Months | Current |
| Kamal Kishore Pahwa | Managing Director | 12 Aug 2022 | 4 Years 3 Months | Current |
| Ashwani Kumar Sharma | Director | 12 Aug 2022 | 4 Years 3 Months | Current |
Auditor
Medicamen Life Sciences Private Limited is audited by Rai Qimat & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rai Qimat & Associates | FY 2023 | 013152C |
Shareholding
The shareholding of Medicamen Life Sciences Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Medicamen Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹9.42 Cr
Satisfied charges
₹1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Mar 2025 | 101096664 | Others | ₹9 Cr | Open | |
| 28 Jul 2023 | 100766631 | Hdfc Bank Limited | ₹41.88 Lakh | Open | |
| 19 Jan 2024 | 100855220 | Hdfc Bank Limited | ₹1 Cr | Satisfied |
To see the full charge records of Medicamen Life Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Medicamen Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medicamen Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medicamen Life Sciences Private Limited has a workforce of 114 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
114
Active EPFO establishments
1
Employee growth
5.6%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 114 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Medicamen Life Sciences Private Limited, buy the company report.
GST
Medicamen Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAQCM0862K1Z1 | Delhi | Active | 05 Oct 2022 |
To see the full GST registrations and return filing status of Medicamen Life Sciences Private Limited, buy the company report.
Recent activity
Medicamen Life Sciences Private Limited has 9 board changes on record since 2022: 5 appointments and 4 cessations. The latest: Shaival Saurabh ceased to be Additional Director on 29 Sep 2025.
Charges
A charge registered on 19 Jan 2024 via Charge ID 100855220 with Hdfc Bank Limited was fully satisfied on 03 Jan 2026.
AGM
Medicamen Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Shaival Saurabh ceased to be Additional Director.
Ceased
Sham Goel ceased to be Additional Director.
Appointed
Shaival Saurabh was appointed as Director.
Appointed
Sham Goel was appointed as Director.
Charges
A charge with Others of Rs. 9.00 Cr registered on 28 Mar 2025 with Charge ID 101096664 was modified on 27 Jun 2025.
Filing
Medicamen Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge with Others amounted to Rs. 9.00 Cr with Charge ID 101096664 was registered on 28 Mar 2025.
Ceased
Kamal Kishore Pahwa ceased to be Director.
Ceased
Pramod Kumar Sharma ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.00 Cr with Charge ID 100855220 was registered on 19 Jan 2024.
5 earlier events are in the company report.
News
Frequently asked questions
Medicamen Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 August 2022 (4+ years old) and is registered under CIN U24290DL2022PTC403121.
Medicamen Life Sciences has 5 current directors:
- Kamal Kishore Pahwa - Managing Director
- Shaival Saurabh - Director
- Rahul Bishnoi - Director
- Sham Goel - Director
- Ashwani Kumar Sharma - Director
The latest financial statements of Medicamen Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Medicamen Life Sciences is 07AAQCM0862K1Z1, registered in Delhi.
The CIN (Corporate Identification Number) of Medicamen Life Sciences is U24290DL2022PTC403121. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medicamen Life Sciences was incorporated on 12 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Shaival Saurabh ceased to be Additional Director on 29 Sep 2025. Sham Goel ceased to be Additional Director on 29 Sep 2025. Shaival Saurabh was appointed as Director on 12 Aug 2025. Medicamen Life Sciences has 9 board changes on record in total.
Yes, Medicamen Life Sciences is registered as an MSME under Udyam registration (number: UDYAM-DL-08-0035438).
Medicamen Life Sciences can be reached through the website medicamen.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Medicamen Life Sciences is at 1009 & 1010 10th Floor Chiranjiv Tower, Nehru Place New Delhi, Delhi, India – 110019.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages